Quantcast
Last updated on April 17, 2014 at 21:23 EDT

Latest Herpes zoster Stories

2012-06-04 18:20:42

PASADENA, Calif., June 5, 2012 /PRNewswire/ -- People who have had an episode of herpes zoster, also known as shingles, face a relatively low short-term risk of developing shingles again, according to a Kaiser Permanente Southern California study published online in the Journal of Infectious Diseases. These findings suggest that among people with immune systems that have not been compromised, the risk of a second shingles episode is low. Researchers reviewed electronic health records and...

2012-04-23 13:04:43

Kaiser Permanente study found no serious reactions to vaccine The herpes zoster vaccine, also known as the shingles vaccine, is generally safe and well tolerated according to a Vaccine Safety Datalink study of 193,083 adults published online in the Journal of Internal Medicine. More than 1 million people develop shingles every year in the United States. Shingles is a painful contagious rash caused by the dormant chickenpox virus which can reactivate and replicate, damaging the nerve...

2012-04-23 06:28:11

PASADENA, Calif., April 23, 2012 /PRNewswire/ -- The herpes zoster vaccine, also known as the shingles vaccine, is generally safe and well tolerated according to a Vaccine Safety Datalink study of 193,083 adults published online in the Journal of Internal Medicine. More than 1 million people develop shingles every year in the United States. Shingles is a painful contagious rash caused by the dormant chickenpox virus which can reactivate and replicate, damaging the nerve system. The elderly...

2012-01-23 21:05:00

VyGone Inhibitor Zapper brings quick, effective relief for genital warts, cold sores, herpes and other uncomfortable and embarrassing conditions before they ever appear. Springville, UT (PRWEB) January 23, 2012 With almost 6 million people contracting new cases of genital warts each year in the US, there has been a growing demand for faster, more effective genital warts treatment. Finally, the solution is here. The VyGone Inhibitor Zapper uses electro waveform technology to treat the...

2012-01-11 15:20:42

A new clinical Standard Reference Material (SRM) from the National Institute of Standards and Technology (NIST) will help health care professionals more accurately diagnose and treat cytomegalovirus (CMV), a common pathogen that is particularly dangerous for infants and persons with weakened immune systems. CMV is found in 50 to 80 percent of the population. It is a member of the herpes family of viruses that includes two herpes simplex viruses (the causes of cold sores and genital...

2012-01-04 07:54:00

BALTIMORE, Jan. 4, 2012 /PRNewswire/ -- Arcion Therapeutics, a clinical stage biotechnology company developing topical therapies for chronic pain, today announced that it received notice of allowance for a US Patent for its high strength gel formulation of topical lidocaine, ARC-2022. ARC-2022 is being developed by Arcion for pain associated with post-herpetic neuralgia (PHN) and shingles. ARC-2022 has been evaluated in a single-dose Phase 1 pharmacokinetic study in adult patients...

Researchers Say Sunlight May Curb Spread Of Chickenpox
2011-12-20 06:02:16

According to a study published this week by scientists at the University of London, children who soak up more rays from the sun may actually be less likely to spread the virus associated with chickenpox. The results of the study were published in the scientific journal Virology and indicated that the UV rays in sunlight may serve to ℠deactivate´ the viruses on the surface of the skin, thus making it more difficult for the virus to spread to new hosts. Researchers compared...

2011-09-19 03:00:00

MELBOURNE, Australia, September 19, 2011 /PRNewswire/ -- Spinifex Pharmaceuticals, an Australian pain drug development company, today announced the first patients have been treated in its Phase 2 clinical trial of EMA401 in postherpetic neuralgia (PHN), a painful condition that develops in some patients following herpes zoster (shingles) and where existing therapy does not relieve pain in all individuals. The double-blind, placebo-controlled randomised trial is being...

2011-08-09 07:00:00

SAN MATEO, Calif., Aug. 9, 2011 /PRNewswire/ -- Recent Highlights: Completed equity and debt financing totaling $40 million Qutenza® (capsaicin) 8% patch launch in U.S. building momentum in large U.S. institutions; 432 institutions purchased as of 2Q11, up 34% from 1Q11 Sales of Qutenza to end user customers increased 23% over 1Q11 2Q11 revenue totaled $2.5 million including $0.5 million U.S. Qutenza product revenue EU launch by Astellas advancing, with Qutenza...

2011-06-27 21:25:07

Herpes infections on the lips, in the eyes or on the nose are painful, long-lasting and unpleasant. A new 3D herpes infection model brings hope: active ingredients and new treatments can be reliably tested with this model. Animal tests could soon be a thing of the past. It burns and itches on your upper lip: a herpes infection is on the advance. Caught early, the number and size blisters can be controlled with virus-controlling salves, but the herpes simplex virus can recur at any time....


Latest Herpes zoster Reference Libraries

69_7b87211f9314eacab994d465558a3a1b
2011-01-24 12:56:26

Herpes zoster (or zoster), is known as shingles or zona and is a viral disease characterized by painful skin rash with blisters in a limited area on one side of the body. Initial infection causes chickenpox. Once chickenpox is over the virus remains in the body and can cause shingles. It can become latent in the nerve cell bodies and sometimes in the dorsal root, cranial nerve, or autonomic ganglion. Years after initial infection, another breakout can cause a painful rash. The rash usually...

More Articles (1 articles) »